PABLO
ROJO CONEJO
Profesor titular de universidad
Harvard University
Cambridge, Estados UnidosHarvard University-ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2023
-
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
PLoS ONE, Vol. 18, Núm. 1 January
-
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium
eClinicalMedicine, Vol. 64
-
Potential pitfalls in the use of real-world data for studying long COVID
Nature Medicine
2022
-
International comparisons of laboratory values from the 4CE collaborative to predict COVID-19 mortality
npj Digital Medicine, Vol. 5, Núm. 1
2021
-
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
BMC infectious diseases, Vol. 21, Núm. 1, pp. 5
2020
-
Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis
Journal of the International AIDS Society, Vol. 23, Núm. 4
2019
-
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 list
The Lancet HIV, Vol. 6, Núm. 9, pp. e623-e631
2018
-
The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis
PLoS Medicine, Vol. 15, Núm. 3
2016
-
Safety of darunavir and atazanavir in HIV-infected children in Europe and Thailand
Antiviral Therapy, Vol. 21, Núm. 4, pp. 353-358